Lab Notes: Code Bio makes potential $2B deal; Marinus suffers Covid-related setback By: Philadelphia Business Journal via Business Journals February 25, 2022 at 13:35 PM EST The Center for Breakthrough Medicines has formed a cell and gene therapy partnership with a Philadelphia CRO. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
